17.9 C
New York
Wednesday, June 3, 2026

Tag: patents

newssourceFORcompanyinformationcontent1marketreleases

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and...

Surfx Technologies, LLC files federal lawsuit for patent infringement against ONTOS Equipment Systems, Inc.

REDONDO BEACH, Calif., June 2, 2026 /PRNewswire/ -- Surfx Technologies, LLC ("Surfx"), the market leader in atmospheric argon plasma systems for semiconductor manufacturing, announced today...

Alitheon Secures $8 Million Series A1 to Scale “Biometrics for Things” Across Global Supply Chains

Alitheon®, the advanced optical-AI pioneer, today announced the closing of the round led by Emerald Technology Ventures, with significant participation from eBay Ventures and...

Beam Global Deploys Six More EV ARC™ Systems for the City of Long Beach

Beam Global deploys six EV ARC™ systems for the City of Long Beach, including two at Long Beach Airport, to support municipal EV fleet charging.

STAK Inc. Accelerates New Energy Vehicle Expansion with Growing Product Portfolio and Intellectual Property

CHANGZHOU, China, June 2, 2026 /PRNewswire/ -- STAK Inc. (the "Company" or "STAK") (Nasdaq: STAK), a fast-growing company specializing in the research, development, manufacturing, and sale...

Nanobiotix Joins the Euronext Tech Leaders Index

PARIS and CAMBRIDGE, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced its inclusion in the Euronext Tech Leaders segment and Euronext Tech Leaders Index, a Euronext flagship initiative dedicated to increasing the visibility and attractiveness of Europe’s leading and high-growth technology companies among international investors.

Nxera’s Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea

Tokyo, Japan and Cambridge, UK, 2 June 2026 – Nxera Pharma Co., Ltd. (“Nxera” or the “Company”)　 announces that the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea has granted Orphan Drug Designation (ODD) and Global Innovative Products on Fast Track (GIFT) designation to vamorolone for the treatment of Duchenne muscular dystrophy (DMD). The Company plans to submit a Marketing Authorization Application (MAA) for vamorolone in South Korea during 2026.

Greystone Names Sahil Sagar as Chief Information and AI Officer

Greystone names Sahil Sagar as Chief Information & AI Officer; most recently at Citi, he brings 20+ years in AI/tech leadership.

Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years

Next Hydrogen Reports Q2 2025 Financial Results

MISSISSAUGA, Ontario, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Next Hydrogen Solutions Inc. (the “Company” or “Next Hydrogen”) (TSXV:NXH, OTC:NXHSF), a designer and manufacturer of electrolyzers, is pleased to report its financial results for the second quarter ended June 30, 2025.

24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025

2H 2025 is shaping up to be a defining year for LIXTE (Nasdaq: LIXT) and its lead compound LB-100

Beam Global Announces Second Quarter 2025 Operating Results

Beam Global to Release Q2 2025 Operating Results, Conference Call Scheduled for Thursday, August 14, 2025 at 4:30 p.m. ET.

NANO Nuclear Reports Third Fiscal Quarter 2025 Financial Results and Provides Business Update

New York, N.Y., Aug. 14, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today reported its third fiscal quarter financial results and provided a business update.

Edible Garden Delivers Strong Performance Across Core and Key Segments, Driven by Strategic Portfolio Transformation

 Company exits low-margin product lines, invests in higher-margin, innovative CEA-informed, better-for-you shelf-stable products, and expands global reach

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatents

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers